FDA Inspection 1059764 — Epaminondas Zakynthinos, M.D., PhD, Principal Investigator
The FDA completed an inspection of Epaminondas Zakynthinos, M.D., PhD, Principal Investigator on Apr 20, 2018 in Larissa. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 20, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Larissa (Greece)
Additional Details
Clinical Investigator (CI)